/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
Zimmer Biomet Holdings, Inc. (ZBH), headquartered in Warsaw, Indiana, designs, develops, manufactures, and markets medical equipment. Valued at $22.6 billion by market cap, the company offers orthopedic, dental, and spinal reconstructive implants, as well as bone cement and related surgical products. The orthopedic device maker is expected to announce its fiscal second-quarter earnings for 2024 before the market opens on Wednesday, Aug. 7.
Ahead of the event, analysts expect ZBH to report a profit of $1.98 per share on a diluted basis, up 8.8% from $1.82 per share in the year-ago quarter. The company beat or matched the consensus estimates in the last four quarters.